We are fortunate to have the support of a panel of respected medical experts with extensive experience in CGD. The members of the panel review the medical content of this website together with all of our publications to ensure that the information we provide is accurate and up-to-date.
Professor Andrew Gennery
Professor Gennery is a clinical reader and consultant in paediatric immunology and haematopoietic stem cell transplantation and honorary consultant paediatric immunologist at the Great North Children’s Hospital in Newcastle.
The Great North Children’s Hospital in Newcastle is a specialist centre for BMT for CGD and other immune deficiencies. Andrew’s research interests include primary immunodeficiency and the reconstitution of the immune system after haematopoietic stem cell transplantation.
Professor David Goldblatt
David is Professor of Vaccinology and Immunology at UCL and Deputy Director for NHS Engagement at the Institute of Child Health. He is also a Consultant Paediatric Immunologist at Great Ormond Street Hospital (GOSH), where he leads Clinical Research and the NIHR GOSH/UCL Biomedical Research Centre.
He holds a medical degree from the University of Cape Town, a PhD in Immunology from the University of London, and was named an NIHR Senior Investigator in 2012. David has cared for CGD families at GOSH since the mid-1990s.
Dr David Lowe
Dr Lowe is a Consultant Clinical Immunologist, Royal Free London NHS Foundation Trust and Honorary Clinical Senior Lecturer at University College London. Dr Lowe went to medical school in Cambridge and undertook an immunology PhD at Imperial College London and the University of Cape Town, South Africa. He now runs the CGD clinic in collaboration with local colleagues works the Royal Free Hospital. His clinical and research interests are on the infectious complications of primary immune deficiency.
Dr Janine Reichenbach
Dr Reichenbach is a consultant paediatrician at the Children’s Hospital, Zurich, Switzerland, a major centre for research and treatment of CGD.
Janine is an expert on the treatment and care of CGD and has an active research programme on CGD. Her research interests include optimising reduced intensity chemotherapy protocols for BMT for paediatric and adult CGD patients and developing gene therapy for the p47phox deficient form of CGD.
Dr Sergio Rosenzweig
Dr Rosenzweig is the Director of the Primary Immunodeficiency Clinic at the National Institutes of Health in the USA.
Sergio is a pediatrician and immunologist with more than 20 years experience in hands-on diagnosis, treatment, follow up and research on primary immunodeficiency diseases. Sergio’s contributions to the field include a focus on chronic granulomatous disease and the diagnosis and treatment of primary immunodeficiency diseases. Sergio is currently also working on genetic susceptibility to fungal infections.